Evidence-based guides on acoustic voice analysis for speech-language pathologists
Traditional perturbation measures aren't obsolete—but they have critical limitations. Learn when jitter and shimmer are valid, when they fail (severe dysphonia), why ASHA now recommends CPP as primary, and how Praat vs MDVP give different values.
Can you trust voice recordings from a smartphone? The Bridge2AI-Voice Consortium and 2020-2025 validation studies reveal which parameters work (F0, CPP) and which don't (shimmer, HNR). Learn the evidence-based protocols that make smartphone recordings clinically valid.
Single acoustic parameters can't capture the full complexity of voice quality. Learn how AVQI and ABI combine multiple measures into validated scores that correlate with perceptual ratings, plus validated cutoffs for Brazilian Portuguese.
CPP has emerged as the most reliable acoustic measure for detecting dysphonia. Learn why researchers and clinicians are moving beyond traditional jitter/shimmer measurements, and how to interpret CPP values in your clinical practice.
How to interpret wideband and narrowband spectrograms for clinical voice assessment. Patterns, pathologies, and practical applications.
Evidence-based pitch targets, the role of resonance, and how to track progress in gender-affirming voice therapy.
We're always looking for topics that would help voice clinicians in their practice.
Suggest a topic →Dr. Jorge C. Lucero
Professor of Computer Science, University of Brasília
Dr. Lucero has over 30 years of experience researching voice production and vocal fold dynamics. He has published 40+ peer-reviewed papers on voice science and developed SimuVox, a physics-based voice synthesis tool. His goal with PhonaLab is to make professional voice analysis accessible to all clinicians.
Educational Content: Articles on this blog are provided for educational purposes to support evidence-based clinical practice. Content is not intended as medical advice. Clinical decisions should be made by qualified healthcare professionals based on individual patient assessment.